Trial Profile
The clinical application of ultrasonic contrast agent in the treatment of uterine fibroids with ultrasound-guided high intensity focus ultrasound
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Uterine leiomyoma
- Focus Diagnostic use
- 23 Jan 2018 New trial record